NUIG –www.nuigalway.ie – AutoCRAT Coordinator
Established in 1845, the National University of Ireland, Galway, is a research-led university ranked among the top 2% of universities in the world (QS World rankings 2019 and the Times Higher Education World University Rankings for 2019-20).
The Regenerative Medicine Institute (REMEDI) is a world-class, state-of-the-art research biomedical research centre at NUIG, whose main focus is research into regenerative medicine. REMEDI is a collaborative effort involving scientists, clinicians and engineers who share a vision for the development of novel therapies and tissue engineering solutions for human diseases using adult stem cells and gene therapies, with osteoarthritis as a major disease focus.
NUIG will be involved in all aspects of AutoCRAT. The NUIG team will work on discovery and validation of novel regenerative cell therapeutics. NUIG will lead workstreams on (i) development of GMP-compliant, scalable, automatable AutoCRAT production processes and (ii) regulatory compliance and economic evaluation of the AutoCRAT production platform. NUIG will also lead on ethics and project management.